Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Cash & Equivalents (2020 - 2025)

Upexi's Cash & Equivalents history spans 6 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 297.88% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, up 297.88%, while the annual FY2025 figure was $3.0 million, 349.82% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.6 million at Upexi, down from $2.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $14.5 million in Q2 2021 and bottomed at $224318.0 in Q1 2024.
  • The 5-year median for Cash & Equivalents is $2.2 million (2021), against an average of $3.6 million.
  • The largest annual shift saw Cash & Equivalents soared 2460.84% in 2021 before it tumbled 87.43% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $6.6 million in 2021, then tumbled by 31.65% to $4.5 million in 2022, then tumbled by 87.43% to $566677.0 in 2023, then decreased by 28.29% to $406347.0 in 2024, then soared by 297.88% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for UPXI's Cash & Equivalents are $1.6 million (Q4 2025), $2.2 million (Q3 2025), and $3.0 million (Q2 2025).